SCHEMBL7954430

SCHEMBL7954430

COc1ccc(Cn2c(C(N)=O)nc3c(C(=O)O)cccc32)cc1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
PARP1 P09874 3/20 0.52
TSPO P30536 2/20 0.48
FABP4 P15090 1/20 0.47
DCTPP1 Q9H773 1/20 0.47
CHRM1 P11229 1/20 0.46
CD38 P28907 1/20 0.44
PPARG P37231 2/20 0.44
CCR2 P41597 1/20 0.44
TBXA2R P21731 1/20 0.44
TP53 P04637 2/20 0.43
LMNA P02545 1/20 0.43
USP2 O75604 1/20 0.43
PKN1 Q16512 1/20 0.43
PKN2 Q16513 1/20 0.43
KDM4E B2RXH2 1/20 0.43
ALDH1A1 P00352 1/20 0.43
GLA P06280 1/20 0.43
GAA P10253 1/20 0.43
HPGD P15428 1/20 0.43
CASP1 P29466 1/20 0.43

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL7966864 0.90 PARP1 (0.51) PARP1TSPODCTPP1CD38TP53
SCHEMBL7965376 0.87 TSPO (0.54) PARP1TSPOFABP4DCTPP1CHRM1
SCHEMBL7483323 0.87 TSPO (0.47) TSPOFABP4DCTPP1CHRM1PPARG
SCHEMBL8601846 0.81 PPARG (0.48) TSPOFABP4DCTPP1CHRM1PPARG
SCHEMBL7966866 0.81 CCR2 (0.46) TSPODCTPP1CCR2TP53LMNA
SCHEMBL7427558 0.78 TSPO (0.47) PARP1TSPODCTPP1TBXA2RLMNA
SCHEMBL7966547 0.78 TSPO (0.54) TSPODCTPP1TBXA2RKDM4EALDH1A1
SCHEMBL8622660 0.76 PARP1 (0.64) PARP1PPARGTP53LMNAPKN1
SCHEMBL1081597 0.74 PLA2G2A (0.45) ALDH1A1AURKARPS6KB1
SCHEMBL6953212 0.70 PPARG (0.50) PARP1DCTPP1PPARGTBXA2RUSP2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-6316482-B1 FOR THERAPY AND PROPHYLAXIS OF HYPERTENSION, HEART FAILURE, RENAL INSUFFICIENCY, EDEMA, ASCITES, VASOPRESSIN PARASECRETION SYNDROME, HEPATOCIRRHOSIS, HYPONATREMIA, HYPOKALEMIA, DIABETIC, CIRCULATION DISORDER, CEREBROVASCULAR DISEASE FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-11-13 US disclosed
US-6207693-B1 Benzamide derivatives having a vasopressin antagonistic activity FUJISAWA PHARMACEUTICAL CO., LTD. (JP) 2001-03-27 US disclosed